Investigating the Impact of Supply Chain Dynamics on Financial Performance with Supply Chain Disruption Structure Approach by Ebrahim Farbod, Alireza Hamidieh, Hootan Amininia

“…The statistical sample of the present study is 217 business managers of pharmaceutical companies according to the formula for determining the sample size of Cochran, observing the success ratio in this research and considering the error coefficient of 0.05. …”
Get full text

Advances in Chemical Synthesis of Fondaparinux by Yili Ding, Chamakura V. N. S. Vara Prasad, Bingyun Wang

“…Over the last two decades, several research groups and pharmaceutical companies have been interested in finding efficient and practical methods for its synthesis. …”
Get full text

EFFECT OF WORKING CAPITAL MANAGEMENT ON FIRM’S VALUE: EVIDENCE FROM LISTED PHARMACEUTICAL FIRMS IN NIGERIA by Muhammed BELLO, Adeyemi KAMARDEEN, Shakirat Opeyemi SALAWUDEEN

“…The population of this study consists of all listed pharmaceutical companies on the floor of the Nigeria Exchange Group as at 31st December, 2021. …”
Get full text

Glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonists for the treatment of obesity and diabetes mellitus by Alexander C. Martins, Beatriz G. de la Torre, Fernando Albericio

“…Health authorities are working to address this issue, while pharmaceutical companies are exploring new paths to improve the quality of these drugs. …”
Get full text

THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY by O. Ageeva, A. Yolkina

“…The best methods of identification of the financial assets and liabilities with highest risk concentration on the example of pharmaceutical companies have been considered. It is well known, that significant risks are subject to disclosure in financial statements of organization, because they can influence management decisions. …”
Get full text

The Canadian Multicentre MAC Treatment Study by Stephen D Shafran, The Canadian HIV Trials Network

“…A Canadian Multicentre MAC Treatment Trial was proposed in 1990 and finally implemented in late 1992 via the Canadian HIV Trials Network with the assistance of 6 pharmaceutical companies. The specific drug regimens and study design are outlined and the timetable for analysis and completion are also indicated. …”
Get full text

Healthcare consumers' perceptions of incentive-linked prescribing: A scoping review. by Muhammad Naveed Noor, Haider Safdar Abbasi, Nina van Der Mark, Zahida Azizullah, Janice Linton, Afifah Rahman-Shepherd, Amna Rehana Siddiqui, Mishal Sameer Khan, Rumina Hasan, Sadia Shakoor

“…In addition to strong regulatory controls, it is critical that physicians self-regulate their behaviour, and publicly disclose if they have any financial ties with pharmaceutical companies. Doing so can contribute to trust between patients and physicians, an important part of patient-focused care and a contributor to user confidence in the wider health system.…”
Get full text

A Better Code for a Better Relationship by Russell Williams, Paul C Adams

Get full text

mRNA vaccine politics: responsible governance coordination for vaccine innovation in times of urgency by Katerina Sideri

“…I argue that the dominant vision of global scalability by pharmaceutical companies which are ‘too big to fail’ limits the transformative potential of the hub and I propose ways in which responsible governance coordination can address some of the failings of the system.…”
Get full text

Médicaments génériques : pivot de la reconstruction de l’industrie pharmaceutique by Philippe Abecassis, Nathalie Coutinet

“…While some of these regulations was designed against major pharmaceutical companies (Big Pharma), firms have often co-constructed the regulation with the intent to take advantage. …”
Get full text

Omicron: The rising fear for another wave in Malaysia by Lydia Ngiik-Shiew Law, Ke-Yan Loo, Joanna Xuan Hui Goh, Priyia Pusparajah

“…Many innocent lives were lost, and the spread of infection is still ongoing. Pharmaceutical companies raced against the time to develop vaccines, believing that it would be sufficient to control COVID-19. …”
Get full text

TRANSFORMATIONAL TRENDS AND INNOVATIVE FACTORS IN THE DEVELOPMENT OF THE WHOLESALE AND RETAIL SECTORS OF THE PHARMACEUTICAL MARKET by E. A. Bykova

“…The article gives the ratings of the leading distribution pharmaceutical companies in Russia and analyses the peculiarities of their structural changes under the influence of innovative development factors. …”
Get full text

The need for Open Labs for fostering interdisciplinarities in Modern Chemistry. Biocatalysis: a necessary tool for synthetic chemists by Martin, Juliette

“…However, enzymatic catalysis is a mature technology, and this should encourage more chemists to take further ownership and expand applications in modern chemistry.In the industrial sector, some pharmaceutical companies have been pioneers in the use and acceptance of biocatalysis for the unique properties that enzymes can deliver. …”
Get full text

How to improve psychiatric nosography in the XXI century: a phenomenologist”s viewpoint by Giovanni Stanghellini

“…Classifications of mental disorders reflect much more the minds of psychiatrists than the patients’ minds since these classifications are more focused on the interests of stakeholders (including governmental agencies, advocacy groups, medical insurance, and pharmaceutical companies) than on the experiences of patients. …”
Get full text

Abuse of patent rights for pharmaceuticals in wartime conditions by A.O. Kodynets, O.F. Doroshenko, I.P. Volynets, G.K. Dorozhko, V.O. Petrenko, V.V. Belitsky

“…Examples of patent monopolies in pharmaceuticals owned by major global pharmaceutical companies (Gilead, Merck Sharp & Dohme Corp., etc.) were examined. …”
Get full text

Green strategy for gaining competitive advantage in pharmacy: Exploring the role of green and social innovation by Budi Nur Siswanto, Irayanti Adriant, Rizqi Permana Sari, Agus Rahayu

“…This study aims to explore the influence of green strategy on social innovation and green innovation and its impact on competitive advantage in pharmaceutical companies. A sample of 53 respondents consisting of the private sector and state-owned enterprises was selected in this study and then analyzed using a structural equation model (SEM-PLS). …”
Get full text

Impacts of National Reimbursement Drug Price Negotiation on drug accessibility, utilization, and cost in China: a systematic review by Zheng Zhu, Jiawei Zhang, Zhihu Xu, Quan Wang, Yu Qi, Li Yang

“…Abstract Objective National Reimbursement Drug Price Negotiation (NRDPN) refers to a government-led process of negotiating with pharmaceutical companies to reach reasonable prices for exclusive drugs covered by national reimbursement. …”
Get full text

Clinical trials in health-care metaverse – A conceptual overview by J. Mohammed Sulaiman Sait, S. Sarumathy

“…This review article focuses on the concepts of metaverse, its use in clinical trials, its inherent benefits, and limitations and serves as a starting point for clinical research organizations, pharmaceutical companies, and technology firms to conceptualize and develop metaverse solutions that stand to significantly benefit the broader landscape of clinical trials.…”
Get full text

Sécurité sanitaire sous dépendance by Marie Coris, Alain Piveteau, Philippe Gorry, Matthieu Montalban

“…But the debate has failed to understand the complexity of the determining factors in the location of pharmaceutical companies and to overcome the contradictions at work in this productive and security crisis. …”
Get full text

Undigested Pills in Stool Mimicking Parasitic Infection by Fazia Mir, Ilyas Achakzai, Jamal A. Ibdah, Veysel Tahan

“…Controlled release preparations were developed by pharmaceutical companies to improve compliance and decrease frequency of pill ingestion. …”
Get full text